Compounds > lactose
Page last updated: 2024-08-17

lactose and zanamivir

lactose has been researched along with zanamivir in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Baigent, SJ; Bethell, RC; McCauley, JW1
Andrès, C; Bérard, V; Laroche, C; Lesniewska, E; Pertuy, D; Pourcelot, Y1
Bunker, MJ; Davies, MC; James, MB; Roberts, CJ1
Peppercorn, AF; Steel, HM1
Bhatia, S; Cheng, C; Haag, R; Kerkhoff, Y; Nie, C; Oehrl, A; Parshad, B; Stadtmüller, M; Wolff, T1

Other Studies

5 other study(ies) available for lactose and zanamivir

ArticleYear
Genetic analysis reveals that both haemagglutinin and neuraminidase determine the sensitivity of naturally occurring avian influenza viruses to zanamivir in vitro.
    Virology, 1999, Oct-25, Volume: 263, Issue:2

    Topics: Amino Acid Sequence; Animals; Antiviral Agents; Base Sequence; Cells, Cultured; Chick Embryo; Chickens; Dogs; Erythrocytes; Genes, Viral; Glycosylation; Guanidines; Hemagglutination, Viral; Hemagglutinins, Viral; Influenza A virus; Inhibitory Concentration 50; Lactose; Molecular Sequence Data; Mutation; Neuraminidase; Pyrans; Reassortant Viruses; Sialic Acids; Substrate Specificity; Virus Replication; Zanamivir

1999
Dry powder inhaler: influence of humidity on topology and adhesion studied by AFM.
    International journal of pharmaceutics, 2002, Jan-31, Volume: 232, Issue:1-2

    Topics: Aerosols; Antiviral Agents; Chemistry, Pharmaceutical; Crystallization; Guanidines; Humidity; Lactose; Microscopy, Atomic Force; Powders; Pyrans; Sialic Acids; Zanamivir

2002
A nanoscale study of particle friction in a pharmaceutical system.
    International journal of pharmaceutics, 2006, Nov-15, Volume: 325, Issue:1-2

    Topics: Drug Combinations; Drug Stability; Friction; Lactose; Microscopy, Atomic Force; Nanotechnology; Particle Size; Pharmaceutical Preparations; Polytetrafluoroethylene; Stearic Acids; Surface Properties; Technology, Pharmaceutical; Zanamivir

2006
Fatal respiratory events caused by zanamivir nebulization.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Jul-01, Volume: 51, Issue:1

    Topics: Administration, Inhalation; Adult; Antiviral Agents; Drug Compounding; Fatal Outcome; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lactose; Nebulizers and Vaporizers; Pregnancy; Pregnancy Complications, Infectious; Product Labeling; Ventilators, Mechanical; Zanamivir

2010
Topology-Matching Design of an Influenza-Neutralizing Spiky Nanoparticle-Based Inhibitor with a Dual Mode of Action.
    Angewandte Chemie (International ed. in English), 2020, 09-01, Volume: 59, Issue:36

    Topics: Animals; Antiviral Agents; Dogs; Drug Design; Glycerol; Humans; Influenza A virus; Influenza, Human; Lactose; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Molecular Structure; Nanoparticles; Particle Size; Polymers; Sialic Acids; Surface Properties; Virus Replication; Zanamivir

2020